You are here
Mar 2018 Researchers at the Cleveland Cord Blood Center are studying T cells from the donated umbilical cord blood of newborns as a potential cure for Type 1 Diabetes.
Feb 2018 Dr. Yihua An is the leading researcher in China in the field of stem cell therapies to treat neurological conditions, using UC-MSC, neural stem cells, and other adult stem cells. Dr. An’s team has registered the world’s first phase 3 trials in ClinicalTrials.gov for stem cell therapy of cerebral palsy and spinal cord injury. Dr. An holds multiple Chinese patents related to the preparation and delivery of stem cells for the treatment of brain injury. He has published more than 80 research papers and registered over 27 clinical trials. As of December 2015, Dr. An and his team have treated more than 10,000 patients.
Feb 2018 The first public (donor) bank of cord blood, founded by the Bank of Life Charitable Foundation, started its work in Ukraine. The bank PBKM of Poland provided the initial inventory to launch this project.
Jan 2018 Responsible cord blood banks should provide parents with quality testing results for their baby’s umbilical cord tissue, similar to their quality reports for cord blood storage.
Jan 2018 The 4th annual International Perinatal Stem Cell Society conference is taking place March 1-2, 2018 in Salt Lake City, Utah. A working group will convene to formulate voluntary minimum standards for all products derived from perinatal tissues.
Dec 2017 A study by Cryo-Cell finds that cord blood units collected from multiple births have sufficient numbers of stem cells to treat children for cerebral palsy and other conditions identified in infancy.
Dec 2017 Model Cell Biobank is funded by a patient advocacy charity to offer FREE cord blood banking to UK residents who meet the eligibility criteria.
Dec 2017 NJ Sharing Network will begin banking bone marrow from organ donors, in order to provide more matching bone marrow transplants for minority patients as well as improve the success of organ transplants.
Nov 2017 Immune effector cells are part of the new cancer treatments called Immunotherapy. The Foundation for the Accreditation of Cellular Therapy (FACT) has developed new standards for immune effector cell therapy.
Nov 2017 A key finding of the RAND Corporation is that the social value of the U.S. public cord blood inventory far exceeds the social costs and is worthy of national investment.